MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, AVBP has $349,295K in assets. $25,315K in debts. $62,103K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
1395.08%
Quick Ratio
1395.08%
Cash Ratio
248.46%
Debt to Asset Ratio
7.25%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term investments
    • Cash and cash equivalents
    • Right of use assets - operating ...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
62,103 45,540 112,672 112,765
Short-term investments
264,277 267,281 187,594 122,922
Prepaid expenses and other current assets
22,320 20,076 20,952 14,462
Total current assets
348,700 332,897 321,218 250,149
Long-term investments
--5,108 18,793
Right of use assets - operating leases
370 13 49 85
Deferred offering costs
69 69 --
Other assets
156 190 180 479
Total assets
349,295 333,169 326,555 269,506
Accounts payable
8,727 5,934 5,933 4,060
Accrued expenses
16,169 19,997 15,569 15,478
Operating lease liabilities
99 14 56 98
Total current liabilities
24,995 25,945 21,558 19,636
Operating lease liabilities, net of current amount
320 ---
Total liabilities
25,315 25,945 21,558 19,636
Common stock 0.0001 par value, 200,000,000 shares authorized 45,308,941 and 42,452,251 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively
5 4 4 4
Additional paid-in capital
772,206 711,847 673,884 584,003
Retained Earnings Accumulated Deficit
----334,100
Accumulated deficit
-447,961 -404,641 -369,097 -334,119
Accumulated other comprehensive income (loss)
-270 14 206 -18
Total stockholders' equity
323,980 307,224 304,997 249,870
Total liabilities and stockholders' equity
349,295 333,169 326,555 269,506
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$264,277K Cash and cashequivalents$62,103K Prepaid expenses andother current assets$22,320K Total current assets$348,700K Right of use assets -operating leases$370K Other assets$156K Deferred offering costs$69K Total assets$349,295K Total liabilities andstockholders' equity$349,295K Total stockholders'equity$323,980K Total liabilities$25,315K Accumulated deficit-$447,961K Accumulated othercomprehensive income (loss)-$270K Additional paid-in capital$772,206K Total currentliabilities$24,995K Operating leaseliabilities, net of current...$320K Common stock 0.0001 parvalue, 200,000,000...$5K Accrued expenses$16,169K Accounts payable$8,727K Operating leaseliabilities$99K

ArriVent BioPharma, Inc. (AVBP)

ArriVent BioPharma, Inc. (AVBP)